NASDAQ:POAI Predictive Oncology (POAI) Stock Price, News & Analysis $12.29 -0.70 (-5.39%) As of 10/6/2026 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsSEC Filings About Predictive Oncology Stock (NASDAQ:POAI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Predictive Oncology alerts:Sign Up Key Stats Today's Range$11.94▼$13.1250-Day Range$7.02▼$12.9952-Week Range$0.71▼$16.54Volume362,170 shsAverage Volume473,545 shsMarket Capitalization$41.71 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Predictive Oncology Inc. (NASDAQ: POAI) is a biotechnology company focused on applying artificial intelligence and machine learning to oncology drug discovery and precision medicine. The company combines computational tools with biological data to help identify promising therapeutic candidates and predict how individual tumors may respond to specific treatments. Its technology platform is built around a proprietary collection of tumor samples and associated clinical and drug-response information. Predictive Oncology uses this data to support pharmaceutical and biotechnology companies in evaluating drug candidates, identifying potential biomarkers, and developing more targeted cancer therapies. The company has also offered tumor-profiling and drug-response testing through its Helomics subsidiary and related operations. Predictive Oncology’s business has evolved from earlier precision-medicine and cancer-diagnostics activities toward an artificial-intelligence-driven drug discovery model. Its operations and research collaborations have been based primarily in the United States, although the company’s platform is intended to support pharmaceutical and biotechnology partners more broadly. Specific details about its current leadership structure and geographic commercial reach may change over time.AI Generated. May Contain Errors. Read More Receive POAI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Predictive Oncology and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. POAI Stock News HeadlinesPredictive Oncology (NASDAQ:POAI) Shares Cross Above 50-Day Moving Average - What's Next?October 6 at 4:01 AM | americanbankingnews.comPredictive Oncology (NASDAQ:POAI) vs. GoDaddy (NYSE:GDDY) Head-To-Head ContrastOctober 1, 2026 | americanbankingnews.comA simple options setup that cuts through the noiseIan Cooper says most options traders overcomplicate the process, juggling countless indicators, strategies, and predictions. He argues a simpler approach can work just as well. His free report, The Simple Path To Success With Options, breaks down a repeatable trade setup, common rookie mistakes, and step-by-step blueprints designed to cut through market noise. No complex charts. No guesswork. Just a straightforward setup anyone can learn.October 8 at 1:00 AM | TradeWins (Ad)Predictive Oncology announces name change to Axe ComputeDecember 12, 2025 | msn.comPredictive Oncology rebrands to Axe Compute Inc.December 11, 2025 | msn.comPredictive Oncology Regains Nasdaq ComplianceDecember 2, 2025 | tipranks.comPredictive Oncology regains compliance with Nasdaq minimum stockholder equityDecember 2, 2025 | msn.comPredictive Oncology Regains Compliance with Nasdaq's Minimum Stockholders' Equity RequirementDecember 2, 2025 | markets.businessinsider.comSee More Headlines POAI Stock Analysis - Frequently Asked Questions How have POAI shares performed this year? Predictive Oncology's stock was trading at $7.15 at the beginning of the year. Since then, POAI stock has increased by 71.9% and is now trading at $12.29. How were Predictive Oncology's earnings last quarter? Predictive Oncology Inc. (NASDAQ:POAI) posted its quarterly earnings results on Friday, November, 14th. The medical instruments supplier reported ($4.52) earnings per share for the quarter, missing analysts' consensus estimates of ($1.35) by $3.17. The medical instruments supplier earned $0 million during the quarter, compared to the consensus estimate of $1.50 million. Predictive Oncology had a negative net margin of 5,065.23% and a negative trailing twelve-month return on equity of 732.73%. Read the conference call transcript. When did Predictive Oncology's stock split? Predictive Oncology shares reverse split before market open on Tuesday, September 30th 2025.The 1-15 reverse split was announced on Thursday, September 25th 2025. The number of shares owned by shareholders was adjusted after the market closes on Monday, September 29th 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. How do I buy shares of Predictive Oncology? Shares of POAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Predictive Oncology own? Based on aggregate information from My MarketBeat watchlists, some other companies that Predictive Oncology investors own include Ford Motor (F), Wells Fargo & Company (WFC), Zomedica (ZOM), JPMorgan Chase & Co. (JPM), Abbott Laboratories (ABT), Bank of America (BAC) and Wayfair (W). Company Calendar Last Earnings11/14/2025Today10/08/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorTechnology Industry IT Services Sub-IndustryInternet Services & Infrastructure Current SymbolNASDAQ:POAI CIK1446159 Webwww.precisiontherapeutics.com Phone(651) 389-4800FaxN/AEmployees30Year Founded2002Profitability EPS (Trailing Twelve Months)($13.50) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$12.66 million Net Margins-5,065.23% Pretax Margin-5,082.34% Return on Equity-732.73% Return on Assets-235.55% Debt Debt-to-Equity RatioN/A Current Ratio0.01 Quick Ratio0.01 Sales & Book Value Annual Sales$1.66 million Price / Sales25.06 Cash FlowN/A Price / Cash FlowN/A Book Value($0.46) per share Price / Book-26.72Miscellaneous Outstanding Shares3,394,000Free Float3,353,000Market Cap$41.71 million OptionableNot Optionable Beta1.35 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NASDAQ:POAI) was last updated on 10/8/2026 by MarketBeat.com Staff. From Our PartnersHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredA dividend every week of the yearMost dividend stocks pay quarterly, leaving long stretches of silence between paydays. For investors covering ...Market Savvy | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredLook at Elon’s face after meeting with ChinaElon Musk recently met with Chinese President Xi Jinping, and a former Wall Street Journal Personal Finance Ex...International Living | SponsoredHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as Novemeber. It...Weiss Ratings | SponsoredInside a Former Merrill Lynch Advisor's Income PlaybookA former Merrill Lynch and Vanguard advisor spent 25 years watching one weekly options play generate consisten...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Predictive Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Predictive Oncology With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free POAI Stock Alerts